Literature DB >> 2649413

Acid induced duodenal ulcer pain: the influence of symptom status and the effect of an antispasmodic.

J Y Kang1, I Yap, R Guan, H H Tay, M V Math.   

Abstract

The aims of this study were to determine whether the development of acid induced duodenal ulcer pain was influenced by the symptomatic status of the patient and whether the administration of an antispasmodic could abolish pain. One hundred millilitres of 0.1 N hydrochloric acid was infused onto the ulcer craters or scars of 143 duodenal ulcer patients on 168 occasions. Symptomatic patients were randomised to receive 40 mg of hyoscine intravenously before acid infusion, or to a control group. Typical ulcer pain developed in seven of 55 (13%) instances for non-symptomatic patients, 24/57 (42%) of control symptomatic patients, and 20/56 (36%) of symptomatic patients given hyoscine. (Asymptomatic group v control symptomatic group, p less than 0.005; control symptomatic group v hyoscine group, NS - 95% confidence limits 12% in favour of the control and 24% in favour of the hyoscine group). The results suggest that acid infusion seldom reproduces ulcer pain in non-symptomatic duodenal ulcer patients and that the pathogenesis of acid induced duodenal ulcer pain probably involves a mechanism other than spasm, as pain was not prevented by an anticholinergic.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649413      PMCID: PMC1378296          DOI: 10.1136/gut.30.2.166

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Epigastric pain in duodenal ulcer.

Authors:  J B Dilawari; L M Blendis; D A Edwards
Journal:  Br Med J       Date:  1975-05-03

2.  Further observations on the mechanism of ulcer pain.

Authors:  E C TEXTER; G R VANTRAPPEN; H P LAZAR; E J PULETTI; C J BARBORKA
Journal:  Ann Intern Med       Date:  1959-12       Impact factor: 25.391

3.  Healing of duodenal ulcer with an antacid regimen.

Authors:  W L Peterson; R A Sturdevant; H D Frankl; C T Richardson; J I Isenberg; J D Elashoff; J Q Sones; R A Gross; R W McCallum; J S Fordtran
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

4.  Letter: Confidence limits in evaluating controlled therapeutic trials.

Authors:  H R Wulff
Journal:  Lancet       Date:  1973-10-27       Impact factor: 79.321

5.  Histamine H2-receptor antagonists in the treatment of duodenal ulcers.

Authors:  S Bank; G O Barbezat; B H Novis; L O Tim; H S Odes; C Helman; L Narunsky; P J Duys; I N Marks
Journal:  S Afr Med J       Date:  1976-10-16

6.  Reproduction of epigastric pain of duodenal ulceration by adenosine.

Authors:  A H Watt; D J Lewis; J J Horne; P M Smith
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-03

7.  Acid perfusion of duodenal ulcer craters and ulcer pain: a controlled double blind study.

Authors:  J Y Kang; I Yap; R Guan; H H Tay
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

8.  Most patients with active symptomatic duodenal ulcers fail to develop ulcer-type pain in response to gastroduodenal acidification.

Authors:  A Harrison; J I Isenberg; M Schapira; L Hagie
Journal:  J Clin Gastroenterol       Date:  1982-04       Impact factor: 3.062

9.  Comparison of two doses of cimetidine and placebo in the treatment of duodenal ulcer: a multicentre trial.

Authors: 
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

Review 10.  Duodenitis.

Authors:  S N Joffe; F D Lee; L H Blumgart
Journal:  Clin Gastroenterol       Date:  1978-09
View more
  3 in total

1.  Duodenal ulcer pain--the role of acid and inflammation.

Authors:  J Y Kang
Journal:  Gut       Date:  1994-06       Impact factor: 23.059

Review 2.  pH, healing rate and symptom relief in acid-related diseases.

Authors:  J Q Huang; R H Hunt
Journal:  Yale J Biol Med       Date:  1996 Mar-Apr

Review 3.  Meal-Sensing Signaling Pathways in Functional Dyspepsia.

Authors:  Amanda J Page; Hui Li
Journal:  Front Syst Neurosci       Date:  2018-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.